Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy E Kim

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Angiogenesis in non-small cell lung cancer. A new target for therapyTracy E Kim, John R Murren
Idrugs : the Investigational Drugs Journal|September 10, 2003
Lapatinib ditosylate GlaxoSmithKlineTracy E Kim, John R Murren
Current Opinion in Investigational Drugs (London, England : 2000)|December 25, 2002
Erlotinib OSI/Roche/GenentechTracy E Kim, John R Murren
Clinics in Chest Medicine|March 21, 2002
Therapy for stage IIIB and stage IV non-small cell lung cancerTracy E Kim, John R Murren
Molecular Pharmacology|July 22, 2004
Synergistic antitumor activity of troxacitabine and camptothecin in selected human cancer cell linesTracy E Kim, Shin-Young Park, Chih-Hung Hsu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Angiogenesis in non-small cell lung cancer. A new target for therapyTracy E Kim, John R Murren
Idrugs : the Investigational Drugs Journal|September 10, 2003
Lapatinib ditosylate GlaxoSmithKlineTracy E Kim, John R Murren
Current Opinion in Investigational Drugs (London, England : 2000)|December 25, 2002
Erlotinib OSI/Roche/GenentechTracy E Kim, John R Murren
Clinics in Chest Medicine|March 21, 2002
Therapy for stage IIIB and stage IV non-small cell lung cancerTracy E Kim, John R Murren
Molecular Pharmacology|July 22, 2004
Synergistic antitumor activity of troxacitabine and camptothecin in selected human cancer cell linesTracy E Kim, Shin-Young Park, Chih-Hung Hsu, et al.
Pageof 1